Glycolytic Inhibitors Potentiated the Activity of Paclitaxel and Their Nanoencapsulation Increased Their Delivery in a Lung Cancer Model

• Үндсэн зохиолчид: Andrea Cunha (Зохиогч), Ana Catarina Rocha (Зохиогч), Flávia Barbosa (Зохиогч), Ana Baião (Зохиогч), Patrícia Silva (Зохиогч), Bruno Sarmento (Зохиогч), Odília Queirós (Зохиогч)
• Формат: Ном
• Хэвлэсэн: MDPI AG, 2022-09-01T00:00:00Z.
• Нөхцлүүд: article
• Онлайн хандалт: Connect to this object online.

Antiglycolytic agents inhibit cell metabolism and modify the tumor's microenvironment, affecting chemotherapy resistance mechanisms. In this work, we studied the effect of the glycolytic inhibitors 3-bromopyruvate (3BP), dichloroacetate (DCA) and 2-deoxyglucose (2DG) on cancer cell properties a...